CytomX Therapeutics, Inc. Financial Ratios — CTMX Stock

Profitability (USD)

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-69.48	-26.18	-29.72	-14.44	-19.8	-33.27	-18.52	-33.2	-33.09	-0.25	19.77	-12.77
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.08	-4.58	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-202.25	- -
Gross Margin (%)	100	100	100	100	100	100	100	100	100	100	100	100	100
EBITDA Margin (%)	-1,610.47	-570.85	-414.9	-384.58	-62.27	-127.71	-516.23	-113.94	-303.75	-186.02	-4.26	19.38	-27.54
Operating Margin (%)	-1,684.23	-586.27	-430.54	-396.1	-64.59	-130.88	-525.92	-117.7	-311	-190.61	-6.41	18.1	-29.35
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	85.33	- -
Pretax Margin (%)	-1,704.17	-596.81	-458.56	-391.67	-60.89	-118.15	-495.32	-115.06	-310.54	-186.82	3.28	23.24	-22.48
Profit Margin (%)	-1,705.29	-597.01	-458.69	-391.54	-60.17	-142.19	-493.74	-94.73	-310.54	-186.82	-0.56	23.08	-22.79
Net Income to Common Margin (%)	-2,127.7	-686.94	-545.63	-391.54	-60.17	-142.19	-493.74	-94.73	-310.54	-186.82	-0.56	23.08	-22.79
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	117.12	0.7	- -
Dvd Payout Ratio (%)	19.85	13.09	15.93	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	4	3	- -	- -	- -	- -	28	25	22	18	14	9	4
ST Debt	1	1	- -	- -	- -	- -	3	3	4	4	5	5	4
LT Debt	3	2	- -	- -	- -	- -	25	22	18	14	9	4	- -
Total Debt/EBITDA	-0.29	-0.1	- -	- -	- -	- -	-0.2	-0.32	-0.19	-0.18	-3.24	0.35	-0.2
Net Debt/EBITDA	0.31	2.12	1.87	1.81	3.98	3.26	1.36	2.46	1.81	1.96	3.98	-1.42	0.6
Total Debt/EBIT	-0.28	-0.1	- -	- -	- -	- -	-0.2	-0.31	-0.19	-0.18	-2.16	0.38	-0.19
Net Debt/EBIT	0.3	2.06	1.8	1.76	3.84	3.18	1.33	2.38	1.77	1.91	2.65	-1.52	0.57
EBITDA to Interest Expense	-56.3	-59.51	-18.47	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	-59.19	-62.93	-19.39	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	-58.88	-61.12	-19.17	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	2	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-309.38	-106.95	-59.56	-88.57	-55.19	-68.91	-122.25	-141.55	-183.72	-277.08	-358.51	-573.77	-469.73
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	48.66	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	-7.42	-2.09	- -	- -	- -	- -	-6.38	-4.49	-3	-1.98	-1.32	-0.62	- -
Long-Term Debt/Total Assets (%)	20.76	2.15	- -	- -	- -	- -	7.29	6.04	5.32	5.36	4.65	3.52	- -
Total Debt/Equity (%)	-9.49	-3.8	- -	- -	- -	- -	54.16	-319.91	-4,722	-21.06	-29.45	-2,058.11	4.28
Total Debt/Capital (%)	-10.59	-3.97	- -	- -	- -	- -	-7.11	-5.15	-3.6	-2.56	-1.97	-1.38	-0.6
Total Debt/Total Assets (%)	29.63	4.09	- -	- -	- -	- -	8.11	6.93	6.39	6.92	6.92	7.79	2.8
Net Debt to Equity	10.16	78.19	-47.45	-133.34	-254.02	-189.16	-368.64	2,467.96	44,777.78	225.83	36.19	8,344.74	-12.79
Net Debt/Capital (%)	9.3	44.01	33.74	37.24	44.72	44.01	32.6	28.44	25.46	21.55	2.36	5.28	1.76
EBITDA	-14	-29	-32	-58	-45	-76	-139	-78	-113	-99	-4	27	-21
EBITDA-CapEx	-15	-31	-34	-60	-46	-80	-142	-80	-115	-101	-5	26	-21
Operating Income (Loss)	-15	-30	-33	-60	-46	-78	-141	-81	-116	-101	-6	25	-22

Liquidity (USD)

API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	2.09	5.77	11.86	5.09	6.12	4.45	3.46	4.64	3.92	1.27	1.12	1.17	2.94
Current Ratio	2.22	5.99	12.06	5.26	6.36	4.55	3.54	4.76	3.98	1.55	1.17	1.25	3.09
Quick Ratio	2.14	5.94	11.91	5.15	6.28	4.46	3.46	4.65	3.93	1.5	1.14	1.21	2.98
CFO/Avg Current Liab	- -	4.15	-2.04	-0.08	3.52	-0.95	-1.53	0.07	-1.63	-0.96	-0.36	-0.71	-1.14
Common Equity/Total Assets	-309.38	-106.95	-59.56	-88.57	-55.19	-68.91	-122.25	-141.55	-183.72	-277.08	-358.51	-573.77	-469.73
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	48.66	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	-7.42	-2.09	- -	- -	- -	- -	-6.38	-4.49	-3	-1.98	-1.32	-0.62	- -
Long-Term Debt/Total Assets (%)	20.76	2.15	- -	- -	- -	- -	7.29	6.04	5.32	5.36	4.65	3.52	- -
Total Debt/Equity (%)	-9.49	-3.8	- -	- -	- -	- -	54.16	-319.91	-4,722	-21.06	-29.45	-2,058.11	4.28
Total Debt/Capital (%)	-10.59	-3.97	- -	- -	- -	- -	-7.11	-5.15	-3.6	-2.56	-1.97	-1.38	-0.6
Total Debt/Total Assets (%)	29.63	4.09	- -	- -	- -	- -	8.11	6.93	6.39	6.92	6.92	7.79	2.8
CFO/Total Liabilities	-13.7	20.98	-38.53	-1.68	51.98	-23.15	-48.41	1.44	-35.02	-31.96	-22.48	-71.27	-143.82
CFO/CapEx	-10.94	19.12	-17.2	-0.93	109.28	-19.94	-40.17	2.28	-73.98	-63.67	-66.71	-278.16	-343.58
Altman's Z-Score	-9.04	-1.93	1.22	0.73	1.45	0.67	-1.47	-1.19	-2.29	-4.42	-4.22	-5.63	0.86

Working Capital (USD)

API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	4.81	6.86	11.89	11.65	11.63	489.13	168.75	46.99	2.89	5.14	42.27	29.79
Days Sales Outstanding	- -	75.92	53.17	30.71	31.34	31.4	0.75	2.16	7.77	126.25	71.07	8.64	12.25
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	179	398	785	629	377	302	278	105	114	87	588
- Cash & Cash Equivalents	9	64	60	105	178	248	188	192	206	194	17	38	13
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	4	3	- -	- -	- -	- -	28	25	22	18	14	9	4
Enterprise Value	-4	-61	-7	216	410	193	108	11	-6	-70	-46	-4	455
Total Capital	-40	-75	-117	-176	-219	-315	-390	-483	-602	-705	-709	-682	-708
Total Debt/Capital (%)	-10.59	-3.97	- -	- -	- -	- -	-7.11	-5.15	-3.6	-2.56	-1.97	-1.38	-0.6
Total Debt / EV	-0.93	-0.05	- -	- -	- -	- -	0.26	2.26	-3.74	-0.26	-0.3	-2.2	0.01
EV/Sales	- -	- -	- -	14.38	5.73	3.24	4.02	0.16	- -	- -	- -	- -	5.97
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	2.41	- -	- -	2.09	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	1,501.96	2.39	- -	- -	1.45	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	179	398	785	629	377	302	278	105	114	87	588
Diluted Enterprise Value	-4	-61	120	294	607	382	216	135	94	-70	111	59	579
EV per Share	- -	- -	- -	5.97	11.04	4.63	2.39	0.24	- -	- -	- -	- -	3.3
TTM Sales	1	5	8	15	72	60	27	68	37	53	101	138	76
TTM EBITDA	-14	-29	-32	-58	-45	-76	-139	-78	-113	-99	-4	27	-21
TTM Operating Income	-15	-30	-33	-60	-46	-78	-141	-81	-116	-101	-6	25	-22
TTM Cash Flow to Firm	-8	32	-26	-2	170	-76	-140	5	-119	-111	-56	-86	-76
TTM Free Cash Flow to Firm	-7	34	-24	- -	172	-72	-137	8	-117	-109	-55	-86	-75

Multiples (USD)

API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	-6.95	2,765.41	4.56	-8.77	-2.75	39.94	-2.37	-0.96	-2.07	-1.02	-7.8
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	-4	-61	-7	216	410	193	108	11	-6	-70	-46	-4	455
Low Price	- -	- -	9.01	9.1	10.4	12.51	5.1	3.6	3.68	1.17	1.04	0.83	0.4
EV/Sales	- -	- -	- -	14.38	5.73	3.24	4.02	0.16	- -	- -	- -	- -	5.97
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.73	- -
Price/Earnings Average	- -	- -	-3.23	-7.6	-13.93	-11.27	-3.56	-5.48	-3.71	-1.45	-220.55	4.08	-16.95
Price/Earnings High	- -	- -	-5.04	-12.88	-21.28	-17.24	-6.74	-10.99	-5.56	-3.13	-391.74	15.5	-36.69
Price/Earnings Low	- -	- -	-1.84	-5.6	-8.97	-6.16	-1.74	-2.56	-2.04	-0.77	-134.9	2.21	-3.18
Price/Book Value	- -	- -	-1.53	-2.26	-3.58	-2	-0.9	-0.6	-0.45	-0.15	-0.16	-0.13	-0.83
Price/Book Value Average	- -	- -	-1.16	-2.54	-2.74	-3.03	-1.13	-0.7	-0.69	-0.2	-0.17	-0.19	-0.41
Price/Book Value High	- -	- -	-1.81	-4.3	-4.18	-4.63	-2.15	-1.4	-1.03	-0.43	-0.31	-0.71	-0.9
Price/Book Value Low	- -	- -	-0.66	-1.87	-1.76	-1.65	-0.55	-0.33	-0.38	-0.11	-0.11	-0.1	-0.08
Price/Tangible Book Value	- -	- -	1.45	5.25	11.65	4.9	7.71	-30.56	-114.35	-1.2	-2.33	-43.75	6.02
Price/Tangible Book Value Average	- -	- -	1.1	5.91	8.92	7.42	9.67	-35.95	-177.2	-1.64	-2.55	-65.42	3.02
Price/Tangible Book Value High	- -	- -	1.72	10.01	13.62	11.35	18.33	-72.04	-265.41	-3.55	-4.54	-248.48	6.53
Price/Tangible Book Value Low	- -	- -	0.63	4.35	5.74	4.06	4.73	-16.8	-97.18	-0.88	-1.56	-35.38	0.57
Price/Sales	- -	- -	23.26	26.47	10.95	10.57	14	4.42	7.44	1.98	1.13	0.63	7.71
Price/Sales Average	- -	- -	17.64	29.77	8.38	16.03	17.56	5.2	11.54	2.7	1.24	0.94	3.86
Price/Sales High	- -	- -	27.51	50.44	12.8	24.51	33.28	10.41	17.28	5.85	2.2	3.58	8.36
Price/Sales Low	- -	- -	10.04	21.92	5.4	8.76	8.59	2.43	6.33	1.45	0.76	0.51	0.72
Price/Cash Flow	- -	- -	-6.54	-195.97	4.61	-8.33	-2.68	57.47	-2.33	-0.95	-2.04	-1.01	-7.77
Price/Cash Flow Average	- -	- -	-4.96	-220.4	3.52	-12.63	-3.36	67.6	-3.62	-1.3	-2.24	-1.51	-3.9
Price/Cash Flow High	- -	- -	-7.74	-373.4	5.38	-19.31	-6.37	135.48	-5.42	-2.81	-3.98	-5.73	-8.43
Price/Cash Flow Low	- -	- -	-2.82	-162.27	2.27	-6.9	-1.65	31.59	-1.98	-0.69	-1.37	-0.82	-0.73
Price/Free Cash Flow Average	- -	- -	-5.27	3,110.13	3.49	-13.3	-3.45	46.97	-3.67	-1.32	-2.27	-1.52	-3.91
Price/Free Cash Flow High	- -	- -	-8.22	5,269.13	5.33	-20.33	-6.54	94.14	-5.49	-2.85	-4.04	-5.77	-8.46
Price/Free Cash Flow Low	- -	- -	-3	2,289.83	2.25	-7.27	-1.69	21.95	-2.01	-0.71	-1.39	-0.82	-0.73
EV/Sales Average	- -	- -	9.88	22.82	5.9	11.87	11.58	2.75	6.61	- -	1.21	0.73	3.75
EV/Sales High	- -	- -	19.75	43.48	10.32	20.35	27.31	7.97	12.35	2.55	2.17	3.37	8.25
EV/Sales Low	- -	- -	2.28	14.96	2.92	4.6	2.62	- -	1.4	- -	0.73	0.3	0.61
EV/EBITDA Average	0.31	2.12	-2.38	-5.93	-9.48	-9.29	-2.24	-2.42	-2.18	0.32	-28.38	3.79	-13.63
EV/EBITDA High	0.31	2.12	-4.76	-11.31	-16.58	-15.93	-5.29	-7	-4.07	-1.37	-50.99	17.39	-29.96
EV/EBITDA Low	0.31	2.12	-0.55	-3.89	-4.69	-3.6	-0.51	0.01	-0.46	1	-17.07	1.56	-2.23
EV/EBIT Average	0.3	2.06	-2.29	-5.76	-9.14	-9.07	-2.2	-2.34	-2.12	0.32	-18.86	4.06	-12.79
EV/EBIT High	0.3	2.06	-4.59	-10.98	-15.98	-15.55	-5.19	-6.77	-3.97	-1.34	-33.88	18.62	-28.12
EV/EBIT Low	0.3	2.06	-0.53	-3.78	-4.52	-3.51	-0.5	0.01	-0.45	0.97	-11.35	1.67	-2.09
Last Price	- -	- -	20.87	10.99	21.11	15.1	8.31	6.55	4.33	1.6	1.55	1.03	4.26
High Price	- -	- -	24.68	20.94	24.67	35	19.75	15.44	10.05	4.73	3.02	5.85	4.62
Enterprise Value Average	-4	-61	76	343	423	706	312	189	247	-32	122	101	286
Enterprise Value High	-4	-61	152	654	739	1,211	735	545	461	135	220	465	629
Enterprise Value Low	-4	-61	18	225	209	274	70	-1	52	-99	74	42	47

Shares Outstanding	35	35	36	36	38	45	46	48	65	66	67	80	170
Diluted Weighted Avg Shares	35	35	9	36	37	42	45	46	64	66	74	85	138
Basic Weighted Avg Shares	35	35	9	36	37	42	45	46	64	66	74	84	138
Revenue per Share	0.03	0.15	0.9	0.42	1.93	1.43	0.59	1.48	0.58	0.81	1.37	1.64	0.55
EBITDA per Share	-0.41	-0.83	-3.72	-1.6	-1.2	-1.82	-3.06	-1.69	-1.77	-1.5	-0.06	0.32	-0.15
Operating Income per Share	-0.43	-0.85	-3.86	-1.64	-1.24	-1.87	-3.12	-1.75	-1.81	-1.54	-0.09	0.3	-0.16
Basic EPS, GAAP	-0.54	-1	-4.9	-1.63	-1.16	-2.03	-2.93	-1.4	-1.81	-1.51	-0.01	0.38	-0.13
Basic EPS from Cont Ops	-0.43	-0.87	-4.12	-1.63	-1.16	-2.03	-2.93	-1.4	-1.81	-1.51	-0.01	0.38	-0.13
Diluted EPS, GAAP	-0.54	-1	-4.9	-1.63	-1.16	-2.03	-2.93	-1.4	-1.81	-1.51	-0.01	0.38	-0.13
Diluted EPS from Cont Ops	-0.43	-0.87	-4.12	-1.63	-1.16	-2.03	-2.93	-1.4	-1.81	-1.51	-0.01	0.38	-0.13
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.23	0.91	-3.19	-0.06	4.58	-1.81	-3.1	0.11	-1.86	-1.69	-0.76	-1.02	-0.55
Free Cash Flow per Basic Share	-0.25	0.86	-3.38	-0.12	4.54	-1.9	-3.18	0.06	-1.88	-1.71	-0.77	-1.02	-0.55
Cash & Equivalents per Share	0.25	1.84	21.72	5.02	10.07	10.47	6.53	6.85	4.76	2.95	2.36	1.19	0.99
Book Value per Share	-1.26	-2.24	-13.67	-4.87	-5.9	-7.56	-9.2	-11	-9.72	-11	-9.8	-8.19	-5.16
Tangible Book Value per Share	-1.35	-2.33	14.35	2.09	1.81	3.08	1.08	-0.21	-0.04	-1.33	-0.67	-0.02	0.71

CytomX Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)